Meet our Chief Medical Officer – Monika Tomaszewska-Kiecana MD

With over 30 years of clinical practice and 25+ years in clinical research, Monika brings exceptional expertise to early- and late-phase development. As Principal Investigator in ~200 Phase I–III trials — including numerous biosimilar programs — she has led complex studies across cardiology, oncology, and internal medicine, with a strong focus on patient safety, data […]